RE:Re: Oct 8Commissioning of the 50L facility happened on schedule by the end of Q1 2024 and entered the fine tuning phase with three production runs as of April. Additionally, they delighted with the announcement that the product(PGX-YBG) could be available by year-end pending Health Canada approval. The 100L facility is expected to be commissioned this quarter with industry leader Natex and is the decision point for mass industrialization. Now we see PGX is expected to be showcased on October 8 at a conference of engineers. Based on the general time to publishing PGX-YBG/Fibrosis could also be published in the leading scientific publication Biomaterials in the next 1-2 months. It's all coming together. With approval for the name change of the company the new company name and symbol is very near. While expected in Q3 top-line diagnostic data appears imminent.
Ronald W. Miller, Chair of the Company:
“With the successful completion of this merger, we are now optimized to bring value-driving, transformational products to the market.” Hopeforthebest wrote: Hey proph that they will finally announce to commissioning of the PGX 50 scale is finally completed, after all it has been almost 8 months after the promised completion date and in true gagnon fashion failure and delays and lies